developments in Recombinant Human Serum Albumin for Biopharmaceutical Applications
Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising progress throughout different clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, far more reputable alternative for therapeutic use, nota